Compare CHMG & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHMG | SOPH |
|---|---|---|
| Founded | 1833 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.6M | 462.3M |
| IPO Year | 1995 | 2021 |
| Metric | CHMG | SOPH |
|---|---|---|
| Price | $82.10 | $8.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $57.00 | $7.50 |
| AVG Volume (30 Days) | 47.5K | ★ 474.9K |
| Earning Date | 04-17-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.73 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $37.32 | $23.09 |
| Revenue Next Year | $9.13 | $19.57 |
| P/E Ratio | $22.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.82 | $3.10 |
| 52 Week High | $85.00 | $8.84 |
| Indicator | CHMG | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 57.80 | 71.28 |
| Support Level | $80.54 | $4.63 |
| Resistance Level | $84.86 | N/A |
| Average True Range (ATR) | 1.63 | 0.44 |
| MACD | -0.34 | 0.09 |
| Stochastic Oscillator | 47.49 | 84.06 |
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.